The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26207924 |
32 |
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway. |
Colorado College |
| 25036789 |
45 |
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. |
Swiss Institute of Bioinformatics |
| 22616902 |
165 |
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. |
Ludwig Center For Cancer Research of The University of Lausanne |
| 21726069 |
98 |
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators. |
University of Namur |
| 20055453 |
80 |
Rational design of indoleamine 2,3-dioxygenase inhibitors. |
Institute For Cancer Research |
| 32150677 |
32 |
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to |
Universit£ |
Search and Browse
